Sharps Technology Inc STSS shares are trading lower after the company announced a $3.8 million private placement at $1.69 per share.
What Else?
Sharps Technology says proceeds will be used to support the manufacturing of pre-filled specialty syringe systems through its partnership with Nephron Pharmaceuticals.
See Also: Why Li Auto Shares Are Trading Higher During Wednesday's Session
The offering is expected to close on or about February 3, subject to the satisfaction of customary closing conditions.
According to data from Benzinga Pro, Sharps Technology has a 52-week high of $3.62 and a 52-week low of $0.82.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.